Osteosarcoma is the most common type of bone cancer in dogs. Chemotherapy, limb-sparing procedure and/or amputation remain the mainstay of treatment. However, it is not always feasible.1
Cementoplasty with BIOCERA-VET OSTEOSARCOMA RTU provides a palliative solution, improving the quality of life of the patient suffering from osteosarcoma.1 Its percutaneous injection into lytic bone increases the bone’s mechanical strength, reduces pain and the risk of pathological fractures, therefore providing a minimally invasive, low-cost, and clinically valuable alternative to amputation.1
The clinical indications of BIOCERA-VET OSTEOSARCOMA RTU* are:
• Cementoplasty for palliative care of canine and feline osteosarcoma
• Large bone gaps filling2
*Available to order at Vi for UK and Ireland customers only.
For further information please contact Vi’s technical support team.
Refer to the product IFU prior to use.
To view this product's 'How To' video, please click here.
Please refer to the product IFU for full instructions prior to use. You can view this product's customer testimonials by clicking here.
The above product information is referenced from the Biocera-Vet website;
(1) Biocera-Vet (2022). Osteosarcoma RTU [online]. Available at https://bioceravet.com/en-gb/osteosarcoma/ (accessed on 06,2022)
(2) Biocera-Vet (2022). Osteosarcoma RTU [online]. Available at https://bioceravet.com/wp-content/uploads/2022/05/THV_7676_tec-overview_A4_RAY_1905-without-GR_Osteo.pdf (accessed on 06, 2022)
